Zongertinib and the next chapter of human epidermal growth factor receptor 2-targeted therapy in non-small-cell lung cancer

Shanghai Chest 2026 Open access

Read full text
Authors: Arjun Syal, Noah Osei, Fred R. Hirsch
DOI: 10.21037/shc-2025-1-7
Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations HER2/EGFR in Cancer Research Lung Cancer Research Studies

Publication details

Journal / source
Shanghai Chest
Volume
10
Pages
13–13
Publication date
11 March 2026
Language
EN